Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist/Commentary
Both laboratories found a strong presence of LA. Because our patient was using vitamin K antagonists, the patient's plasma was diluted with normal plasma to reduce the effect of medication before performing LA coagulation assays. The influence of antiphospholipid antibodies on INR values is dep...
Gespeichert in:
Veröffentlicht in: | Clinical chemistry (Baltimore, Md.) Md.), 2017-09, Vol.63 (9), p.1442 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 9 |
container_start_page | 1442 |
container_title | Clinical chemistry (Baltimore, Md.) |
container_volume | 63 |
creator | Schellings, Mark W M de Maat, Moniek P M de Lathouder, Sacha Weerkamp, Floor Eby, Charles S Tripodi, Armando |
description | Both laboratories found a strong presence of LA. Because our patient was using vitamin K antagonists, the patient's plasma was diluted with normal plasma to reduce the effect of medication before performing LA coagulation assays. The influence of antiphospholipid antibodies on INR values is dependent on the reagent used by the clinical laboratory. [...]doubtful results in coagulation testing should always be discussed with a laboratory professional, as was done in this case by the patient himself. [...]they should work to establish an institutional requirement for baseline PT/INR testing before initiating VKA therapy and monitor compliance as a patient safety quality indicator. [...]they should provide a PT mixing study test (1:1 patient plasma and pooled normal plasma) to investigate unexplained prolonged PT results. |
doi_str_mv | 10.1373/clinchem.2016.267245 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1944539981</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1944539981</sourcerecordid><originalsourceid>FETCH-proquest_journals_19445399813</originalsourceid><addsrcrecordid>eNqNirsKwjAYRoMoWC9v4BBwbk2a9JJRvCAI4iCuUmuskeaPJung25vBB3D6vsM5CM0oSSgr2KJuFdQPqZOU0DxJ8yLlWQ9FNGMkLrOc9lFECBGxoLwYopFzz4C8KPMIHY7WtAYaecPh-Yc1-qoAn5SWeHn30uK1crUBr6BT0OCz8pUOwR4vwVeNAeX8YmW0lgHtZ4IG96p1cvrbMZpvN6fVLn5Z8-6k85en6SwEdaGC84wJUVL2X_UFfvJHUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1944539981</pqid></control><display><type>article</type><title>Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist/Commentary</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Schellings, Mark W M ; de Maat, Moniek P M ; de Lathouder, Sacha ; Weerkamp, Floor ; Eby, Charles S ; Tripodi, Armando</creator><creatorcontrib>Schellings, Mark W M ; de Maat, Moniek P M ; de Lathouder, Sacha ; Weerkamp, Floor ; Eby, Charles S ; Tripodi, Armando</creatorcontrib><description>Both laboratories found a strong presence of LA. Because our patient was using vitamin K antagonists, the patient's plasma was diluted with normal plasma to reduce the effect of medication before performing LA coagulation assays. The influence of antiphospholipid antibodies on INR values is dependent on the reagent used by the clinical laboratory. [...]doubtful results in coagulation testing should always be discussed with a laboratory professional, as was done in this case by the patient himself. [...]they should work to establish an institutional requirement for baseline PT/INR testing before initiating VKA therapy and monitor compliance as a patient safety quality indicator. [...]they should provide a PT mixing study test (1:1 patient plasma and pooled normal plasma) to investigate unexplained prolonged PT results.</description><identifier>ISSN: 0009-9147</identifier><identifier>EISSN: 1530-8561</identifier><identifier>DOI: 10.1373/clinchem.2016.267245</identifier><language>eng</language><publisher>Washington: Oxford University Press</publisher><subject>Anticoagulants ; Chemists ; Coagulation ; Colonoscopy ; Glycoproteins ; Immunoglobulins ; Laboratories ; Lupus ; Patients ; Prothrombin ; Thrombosis ; Vitamin K</subject><ispartof>Clinical chemistry (Baltimore, Md.), 2017-09, Vol.63 (9), p.1442</ispartof><rights>Copyright American Association for Clinical Chemistry Sep 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Schellings, Mark W M</creatorcontrib><creatorcontrib>de Maat, Moniek P M</creatorcontrib><creatorcontrib>de Lathouder, Sacha</creatorcontrib><creatorcontrib>Weerkamp, Floor</creatorcontrib><creatorcontrib>Eby, Charles S</creatorcontrib><creatorcontrib>Tripodi, Armando</creatorcontrib><title>Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist/Commentary</title><title>Clinical chemistry (Baltimore, Md.)</title><description>Both laboratories found a strong presence of LA. Because our patient was using vitamin K antagonists, the patient's plasma was diluted with normal plasma to reduce the effect of medication before performing LA coagulation assays. The influence of antiphospholipid antibodies on INR values is dependent on the reagent used by the clinical laboratory. [...]doubtful results in coagulation testing should always be discussed with a laboratory professional, as was done in this case by the patient himself. [...]they should work to establish an institutional requirement for baseline PT/INR testing before initiating VKA therapy and monitor compliance as a patient safety quality indicator. [...]they should provide a PT mixing study test (1:1 patient plasma and pooled normal plasma) to investigate unexplained prolonged PT results.</description><subject>Anticoagulants</subject><subject>Chemists</subject><subject>Coagulation</subject><subject>Colonoscopy</subject><subject>Glycoproteins</subject><subject>Immunoglobulins</subject><subject>Laboratories</subject><subject>Lupus</subject><subject>Patients</subject><subject>Prothrombin</subject><subject>Thrombosis</subject><subject>Vitamin K</subject><issn>0009-9147</issn><issn>1530-8561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNirsKwjAYRoMoWC9v4BBwbk2a9JJRvCAI4iCuUmuskeaPJung25vBB3D6vsM5CM0oSSgr2KJuFdQPqZOU0DxJ8yLlWQ9FNGMkLrOc9lFECBGxoLwYopFzz4C8KPMIHY7WtAYaecPh-Yc1-qoAn5SWeHn30uK1crUBr6BT0OCz8pUOwR4vwVeNAeX8YmW0lgHtZ4IG96p1cvrbMZpvN6fVLn5Z8-6k85en6SwEdaGC84wJUVL2X_UFfvJHUQ</recordid><startdate>20170901</startdate><enddate>20170901</enddate><creator>Schellings, Mark W M</creator><creator>de Maat, Moniek P M</creator><creator>de Lathouder, Sacha</creator><creator>Weerkamp, Floor</creator><creator>Eby, Charles S</creator><creator>Tripodi, Armando</creator><general>Oxford University Press</general><scope>3V.</scope><scope>4U-</scope><scope>7QO</scope><scope>7RV</scope><scope>7TM</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PCBAR</scope><scope>PDBOC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>S0X</scope></search><sort><creationdate>20170901</creationdate><title>Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist/Commentary</title><author>Schellings, Mark W M ; de Maat, Moniek P M ; de Lathouder, Sacha ; Weerkamp, Floor ; Eby, Charles S ; Tripodi, Armando</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_19445399813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Anticoagulants</topic><topic>Chemists</topic><topic>Coagulation</topic><topic>Colonoscopy</topic><topic>Glycoproteins</topic><topic>Immunoglobulins</topic><topic>Laboratories</topic><topic>Lupus</topic><topic>Patients</topic><topic>Prothrombin</topic><topic>Thrombosis</topic><topic>Vitamin K</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schellings, Mark W M</creatorcontrib><creatorcontrib>de Maat, Moniek P M</creatorcontrib><creatorcontrib>de Lathouder, Sacha</creatorcontrib><creatorcontrib>Weerkamp, Floor</creatorcontrib><creatorcontrib>Eby, Charles S</creatorcontrib><creatorcontrib>Tripodi, Armando</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric & Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Earth, Atmospheric & Aquatic Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>SIRS Editorial</collection><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schellings, Mark W M</au><au>de Maat, Moniek P M</au><au>de Lathouder, Sacha</au><au>Weerkamp, Floor</au><au>Eby, Charles S</au><au>Tripodi, Armando</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist/Commentary</atitle><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle><date>2017-09-01</date><risdate>2017</risdate><volume>63</volume><issue>9</issue><spage>1442</spage><pages>1442-</pages><issn>0009-9147</issn><eissn>1530-8561</eissn><abstract>Both laboratories found a strong presence of LA. Because our patient was using vitamin K antagonists, the patient's plasma was diluted with normal plasma to reduce the effect of medication before performing LA coagulation assays. The influence of antiphospholipid antibodies on INR values is dependent on the reagent used by the clinical laboratory. [...]doubtful results in coagulation testing should always be discussed with a laboratory professional, as was done in this case by the patient himself. [...]they should work to establish an institutional requirement for baseline PT/INR testing before initiating VKA therapy and monitor compliance as a patient safety quality indicator. [...]they should provide a PT mixing study test (1:1 patient plasma and pooled normal plasma) to investigate unexplained prolonged PT results.</abstract><cop>Washington</cop><pub>Oxford University Press</pub><doi>10.1373/clinchem.2016.267245</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-9147 |
ispartof | Clinical chemistry (Baltimore, Md.), 2017-09, Vol.63 (9), p.1442 |
issn | 0009-9147 1530-8561 |
language | eng |
recordid | cdi_proquest_journals_1944539981 |
source | Oxford University Press Journals All Titles (1996-Current) |
subjects | Anticoagulants Chemists Coagulation Colonoscopy Glycoproteins Immunoglobulins Laboratories Lupus Patients Prothrombin Thrombosis Vitamin K |
title | Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist/Commentary |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T12%3A34%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolonged%20Prothrombin%20Time%20After%20Discontinuing%20Vitamin%20K%20Antagonist/Commentary&rft.jtitle=Clinical%20chemistry%20(Baltimore,%20Md.)&rft.au=Schellings,%20Mark%20W%20M&rft.date=2017-09-01&rft.volume=63&rft.issue=9&rft.spage=1442&rft.pages=1442-&rft.issn=0009-9147&rft.eissn=1530-8561&rft_id=info:doi/10.1373/clinchem.2016.267245&rft_dat=%3Cproquest%3E1944539981%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1944539981&rft_id=info:pmid/&rfr_iscdi=true |